1,509
Views
1
CrossRef citations to date
0
Altmetric
Review Article

A Review to Populate A Proposed Cost-Effectiveness Analysis of Glaucoma Screening in Sub-Saharan Africa

ORCID Icon, , , , , & show all
Pages 328-338 | Received 22 Jan 2021, Accepted 31 May 2021, Published online: 09 Aug 2021

References

  • Bathija R, Gupta N, Zangwill L, Weinreb RN. Changing definition of glaucoma. J Glaucoma [ Accessed]. 1998;7(3):165–169. http://www.ncbi.nlm.nih.gov/pubmed/9627855. September 14, 2017.
  • Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Seminar glaucoma. Lancet. 2017;390(10108):83–93. doi:10.1016/S0140-6736(17)31469-1.
  • Kyari F, Entekume G, Rabiu M, et al. A population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria national blindness and visual impairment survey. BMC Ophthalmol. 2015;15(1):176.doi:10.1186/s12886-015-0160-6.
  • Ashaye A, Ashaolu O, Komolafe O, et al. Prevalence and types of glaucoma among an indigenous African population in Southwestern Nigeria. Investig Opthalmol Vis Sci. 2013;54(12):7410.doi:10.1167/iovs.13-12698.
  • Budenz DL, Barton K, Whiteside-de Vos J, et al. Prevalence of glaucoma in an urban West African population: the tema eye survey. JAMA Ophthalmol. 2013;131(5):651–658.doi:10.1001/jamaophthalmol.2013.1686.
  • Buhrmann RR, Quigley HA, Barron Y, West SK, Oliva MS, Mmbaga BB. Prevalence of glaucoma in a rural East African population. Invest Ophthalmol Vis Sci. 2000;41:40–48.
  • Quigley HA. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224.
  • Tham Y-C, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040 a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090.doi:10.1016/j.ophtha.2014.05.013.
  • Ntim-Amponsah CT, Amoaku WMK, Ofosu-Amaah S, et al. Prevalence of glaucoma in an African population. Eye (Lond). 2004;18(5):491–497.doi:10.1038/sj.eye.6700674.
  • Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–851. S0042-96862004001100009.
  • Naidoo K, Kempen JH, Gichuhi S, et al. Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2020;104(12):1658–1668.doi:10.1136/bjophthalmol-2019-315217.
  • Heijl A, Bengtsson B, Hyman L, Leske MC. Natural history of open-angle glaucoma. Ophthalmology. 2009;116(12):2271–2276. doi:10.1016/j.ophtha.2009.06.042.
  • Fraser S. Deprivation and late presentation of glaucoma: case-control study. BMJ. 2001;322(7287):639–643. doi:10.1136/bmj.322.7287.639.
  • Ostermann J, Sloan FA, Herndon L, Lee PP Racial differences in glaucoma care. 2020;123.
  • Ellong A, Mvogo CE, Bella-Hiag AL, Mouney EN, Ngosso A, Litumbe CN. [Prevalence of glaucomas in a Black Cameroonian population]. Sante. 2006;16:83–88.
  • Ogbonnaya CE, Ogbonnaya LU, Okoye O, Kizor-Akaraiwe N. Glaucoma awareness and knowledge, and attitude to screening, in a rural community in Ebonyi State, Nigeria. Open Journal of Ophthalmology. 2016;6(6):119–127. doi:10.4236/ojoph.2016.62017.
  • Achigbu EO, Chuka-Okosa CM, Achigbu KI The knowledge, perception and attitude of patients living with glaucoma and attending the eye clinic of a secondary health care facility in South East Nigeria. Vol 23. Wolters Kluwer India; 2014. https://www.ajol.info/index.php/njo/article/view/147216. Accessed April 1, 2017.
  • Adegbehingbe BO, Bisiriyu LA. Knowledge, attitudes, and self care practices associated with glaucoma among hospital workers in Ile-Ife, Osun State, Nigeria. Tanzanian Journal of Health Research. 2008;10(4):240–245.doi:10.4314/thrb.v10i4.45080.
  • Tenkir A, Solomon B, Deribew A. Glaucoma awareness among people attending ophthalmic outreach services in Southwestern Ethiopia. BMC Ophthalmol. 2010; 10 1: Accessed April 12, 2017 10.1186/1471-2415-10-17
  • Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol. 2015;15(1). doi:10.1186/s12886-015-0097-9.
  • Neumann PJ, Sanders GD. Cost-effectiveness analysis 2.0. N Engl J Med. 2017;376(3):203–205. doi:10.1056/NEJMp1612619.
  • Thokala P, Ochalek J, Leech AA, Tong TT. Cost-effectiveness thresholds: the past, the present and the future. Pharmacoeconomics. 2018;36(5):509–522. doi:10.1007/s40273-017-0606-1.
  • Analy- CE The responsibilities of being a physio- therapist Pharmacotherapy of chronic orofacial pain. 2017.
  • Francis AW, Gyasi ME, Adjuik M, et al. Comparison of primary open angle glaucoma patients in rural and urban Ghana. Afr Health Sci. 2014;14(3):729–735.doi:10.4314/ahs.v14i3.32.
  • Dandona L, Dandona R, Mandal P, Shields MB. Open-angle glaucoma in an urban population in southern India the andhra pradesh eye disease study. Am Acad Ophthalmol. 2000;107(2):1702–1709. doi:10.1097/00132578-200104000-00022. Ophthalmol 2000;1071702–1709 © 2000 by.
  • Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a rural population of Southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003;110(8):1484–1490.doi:10.1016/S0161-6420(03)00564-5.
  • Burr JM, Mowatt G, Hernández R, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess (Rockv) 2007;11:41. 10.3310/hta11410
  • Burr J, Hernández R, Ramsay C, et al. Is it worthwhile to conduct a randomized controlled trial of glaucoma screening in the United Kingdom? J Heal Serv Res Policy 2014;19(1):42–51. 10.1177/1355819613499748
  • Vaahtoranta-Lehtonen H, Tuulonen A, Aronen P, et al. Cost effectiveness and cost utility of an organized screening programme for glaucoma. Acta Ophthalmol Scand. 2007;85(5):508–518.doi:10.1111/j.1600-0420.2007.00947.x.
  • Einarson TR, Vicente C, Machado M, Covert D, Trope GE, Iskedjian M. Screening for glaucoma in Canada: a systematic review of the literature. Can J Ophthalmol. 2006;41(6):709–721. doi:10.1139/I06-064.
  • Tang J, Liang Y, O’Neill C, Kee F, Jiang J, Congdon N. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model. Lancet Glob Health. 2019;7(7):e968–e978. doi:10.1016/S2214-109X(19)30201-3.
  • John D, Parikh R. Cost-effectiveness of community screening for glaucoma in rural India: a decision analytical model. Public Health. 2018;155:142–151. doi:10.1016/j.puhe.2017.11.004.
  • Wittenborn JS, Rein DB. Cost-effectiveness of glaucoma interventions in Barbados and Ghana. Optom Vis Sci. 2011;88(1):155–163. doi:10.1097/OPX.0b013e3181fc30f3.
  • Ladapo JA. Projected clinical outcomes of glaucoma screening in African American individuals. Arch Ophthalmol. 2012;130(3):365–372. doi:10.1001/archopthalmol.2011.1224.
  • Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322–338. doi:10.1177/0272989X9301300409.
  • Foster PJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238–242. doi:10.1136/bjo.86.2.238.
  • Kapetanakis VV, Chan MPY, Foster PJ, et al Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. British Journal of Ophthalmology. 2016;100:86–93.
  • Zhang N, Wang J, Li Y, et al. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Scientific Reports. 2021;11,13762. https://doi.org/10.1038/s41598-021-92971-w.
  • Rotchford AP, Kirwan JF, Muller MA, ohnson GJ Roux P. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology. 2003;110(2):376–382. doi:10.1016/S0161-6420(02)01568-3.
  • Rotchford AP, Johnson GJO. Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. Arch Ophthalmol (Chicago, Ill 1960). 2002;120(4):471–478. doi:10.1001/archopht.120.4.471.
  • Rotchford AP. Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. Arch Ophthalmol (Chicago, Ill 1960). 2002;120(4):471–478. doi:10.1001/archopht.120.4.471.
  • Tielsch JM. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore eye survey. JAMA [ Accessed]. 1991;266(3):369–374. http://www.ncbi.nlm.nih.gov/pubmed/2056646. April 12, 2017.
  • Leske MC. The Barbados eye study. prevalence of open angle glaucoma. Arch Ophthalmol (Chicago, Ill 1960). 1994;112(6):821–829. doi:10.1001/archopht.1994.01090180121046.
  • Leske MC, Connell AM, Kehoe R. A pilot project of glaucoma in Barbados. Br J Ophthalmol. 1989;73(5):365–369. doi:10.1136/bjo.73.5.365.
  • Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology. 1989;96(9):1363–1368.doi:10.1016/s0161-6420(89)32708-4.
  • Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol. 2015;15(1):111. doi:10.1186/s12886-015-0097-9.
  • Olawoye O, Tarella S. Spectrum of glaucoma presentation in a Nigerian tertiary hospital. Niger J Ophthalmol. 2014;22(1):11. doi:10.4103/0189-9171.142747.
  • Awoyesuku EA, Ejimadu CS. Visual disability in newly diagnosed primary open angle glaucoma (POAG) patients in a tertiary hospital in Nigeria. Niger J Med. 2012;21(1):78–80.
  • Gyasi ME, Francis AW, Chen Y, Harrison R, Kodjo AR. Presentation of glaucoma in the greater accra metropolitan area of ghana. Ghana Med J. 2014;48(3):143–147. doi:10.4314/gmj.v48i3.4.
  • Mafwiri M, Bowman RJC, Wood M, Kabiru J. Primary open-angle glaucoma presentation at a tertiary unit in Africa: intraocular pressure levels and visual status. Ophthalmic Epidemiol. 2005;12(5):299–302. doi:10.1080/09286580500180572.
  • Giorgis AT, Mulugeta A, Aga A, Deyassa N. The spectrum of glaucoma presentation at Menelik ii hospital, addis ababa. Ethiop Med J. 2012;50:259–264.
  • Kayange PC, Nkume HB, Feyi-Waboso A, Kalua K, Msukwa G, Schwering Schulze M. Presentation of Primary Open Angle Glaucoma (POAG) at lions sight first eye hospital in Blantyre, malawi. Malawi Med J. 2014;26:60–62.
  • Melka F, Alemu B. The pattern of glaucoma in Menelik ii hospital addis ababa, Ethiopia. Ethiop Med J. 2006;44:159–165.
  • Lawan A. Pattern of presentation and outcome of surgical management of primary open angle glaucoma in kano, Northern Nigeria. Ann Afr Med. 2007;6(4):180–185. doi:10.4103/1596-3519.55700.
  • Olawoye O, Tarella S. Spectrum of glaucoma presentation in a Nigerian tertiary hospital. Niger J Ophthalmol. 2015;22(1):11–15. doi:10.4103/0189-9171.142747.
  • Eballe AO, Owono D, Bella AL, Ebana C, Long D, Aboutou R. [Clinical and epidemiological characteristics of chronic open angle glaucoma at a yaounde hospital]. Sante. 2008;18(1):19–23. doi:10.1684/san.2008.0095.
  • Omoti AE, Osahon AI, Waziri-Erameh MJM. Pattern of presentation of primary open-angle glaucoma in Benin City, Nigeria. Trop Doct. 2006;36(2):97–100. doi:10.1258/004947506776593323.
  • Jones PR, Philippin H, Makupa WU, Burton MJ, Crabb DP. Severity of visual field loss at first presentation to glaucoma clinics in England and Tanzania. Ophthalmic Epidemiol. 2020;27(1):10–18. doi:10.1080/09286586.2019.1661499.
  • Rotchford AP, Kirwan JF, Muller MA, Johnson GJ, Roux P. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology. 2003;110(2):376–382. doi:10.1016/S0161-6420(02)01568-3.
  • Zhang S, Sun J, Liu S, et al. Integrating opportunistic glaucoma screening into general health examinations in China: a pilot study. Clin Exp Ophthalmol. 2019;47(8):1000–1008.doi:10.1111/ceo.13564.
  • Song YJ, Kim YW, Park KH, Kim YK, Choi HJ, Jeoung JW. Comparison of glaucoma patients referred by glaucoma screening versus referral from primary eye clinic. PLoS One. 2019;14(1):1–9. doi:10.1371/journal.pone.0210582.
  • Olawoye O, Teng CCC, Ritch R, et al. Evaluation of community eye outreach programs for early glaucoma detection in Nigeria. Clin Ophthalmol. 2013;7:1753. doi:10.2147/OPTH.S46823.
  • Treacy MP, O’Neill EC, Murphy M, et al. Opportunistic detection of glaucomatous optic discs within a diabetic retinopathy screening service. Eur J Ophthalmol. 2016;26(4):315–320.doi:10.5301/ejo.5000722.
  • Kizor-Akaraiwe NN, Monye HI, Okeke S. Awareness and knowledge about glaucoma and proportion of people with glaucoma in an urban outreach programme in Southeast Nigeria. BMJ Open Ophthalmol. 2017;1(1):1–9. doi:10.1136/bmjophth-2016-000018.
  • Kiage D, Kherani IN, Gichuhi S, Damji KF, Nyenze M. The muranga teleophthalmology study: comparison of virtual (teleglaucoma) with in-person clinical assessment to diagnose glaucoma. Middle East Afr J Ophthalmol. 2013;20(2):150–157. doi:10.4103/0974-9233.110604.
  • Munachonga EM, Hall AB, Courtright P. Examination of first-degree relatives of patients with glaucoma: a randomized trial of strategies to increase use in an eye hospital in Africa. Ophthalmic Epidemiol. 2007;14(3):155–159. doi:10.1080/09286580701257633.
  • Kizor-Akaraiwe NN. Follow-up and adherence to glaucoma care by newly diagnosed glaucoma patients in Enugu, nigeria. Ophthalmic Epidemiol. 2019;26(2):140–146. doi:10.1080/09286586.2018.1555263.
  • Harper R, Reeves B. The sensitivity and specificity of direct ophthalmoscopic optic disc assessment in screening for glaucoma: a multivariate analysis. Graefe’s Arch Clin Exp Ophthalmol. 2000;238(12):949–955. doi:10.1007/s004170000209.
  • Cook C, Cockburn N, van der Merwe J, Ehrlich R. Cataract and glaucoma case detection for vision 2020 programs in Africa: an evaluation of 6 possible screening tests. J Glaucoma. 2009;18(7):557–562. doi:10.1097/IJG.0b013e318193c15b.
  • Leske MC. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (Chicago, Ill 1960). 2003;121(1):48–56. doi:10.1001/archopht.121.1.48.
  • Heijl A. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol (Chicago, Ill 1960). 2002;120(10):1268–1279. doi:10.1001/archopht.120.10.1268.
  • De Moraes CGV, Juthani VJ, Liebmann JM, Teng CC, Tello C, Susanna R, Ritch R. Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol. 2011;129(5):562–568.doi:10.1001/archophthalmol.2011.72.
  • Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (Chicago, Ill 1960). 2002;120(6):701–730.doi:10.1001/archopht.120.6.701.
  • Weinreb RN, Societies. A of IG, Lauderdale) GACM on IP (4 : 2007 : f. Intraocular pressure : Reports and Consensus Statements of the 4th Global AIGS Consensus Meeting on Intraocular Pressure LK - Https://Wits.on.Worldcat.Org/Oclc/907177443. Amsterdam SE - 125 p. : ill.;25 cm.: Kugler Publications; 2007.
  • Arora R, Bellamy H, Austin MW. Applanation tonometry: a comparison of the perkins handheld and Goldmann slit lamp-mounted methods. Clin Ophthalmol. 2014;8:605–610. doi:10.2147/OPTH.S53544.
  • Horowitz GS, Byles J, Lee J, D’Este C. Comparison of the tono-pen and goldmann tonometer for measuring intraocular pressure in patients with glaucoma. Clin Exp Ophthalmol. 2004;32(6):584–589. doi:10.1111/j.1442-9071.2004.00907.x.
  • Billy A, David P, Mahabir A, et al. Utility of the tono-pen in measuring intraocular pressure in trinidad: a cross-sectional study. West Indian Med J. 2015;64(4):4.doi:10.7727/wimj.2014.125.
  • Brusini P, Salvetat ML, Zeppieri M, Tosoni C, Parisi L. Comparison of ICare tonometer with Goldmann applanation tonometer in glaucoma patients. J Glaucoma. 2006;15(3):213–217. doi:10.1097/01.ijg.0000212208.87523.66.
  • Nakakura S, Mori E, Fujio Y, et al. Comparison of the intraocular pressure measured using the new rebound tonometer Icare ic100 and Icare TA01i or goldmann applanation tonometer. J Glaucoma. 2019;28(2):172–177.doi:10.1097/IJG.0000000000001138.
  • Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol. 2000;129(3):314–322. doi:10.1016/S0002-9394(99)00414-6.
  • Taubenslag KJ, Kammer JA. Outcomes disparities between black and white populations in the surgical management of glaucoma. Semin Ophthalmol. 2016;31(4):385–393. doi:10.3109/08820538.2016.1154163.
  • Murdoch I, Smith A, Baker H, Shilio B, Dhalla K, Peters RPH. The cost and quality of life impact of glaucoma in Tanzania: an observational study. PLoS One. 2020;15(6):e0232796. doi:10.1371/journal.pone.0232796.
  • Smith AF, Negretti G, Mascaro A, et al. Glaucoma control strategies in Sub-Saharan Africa: a review of the clinical and health economic evidence. Ophthalmic Epidemiol. 2018;25(5–6):419–435.doi:10.1080/09286586.2018.1501499.
  • Mielke C. Deep sclerectomy and low dose mitomycin C: a randomised prospective trial in west Africa. Br J Ophthalmol. 2006;90(3):310–313. doi:10.1136/bjo.2005.079483.
  • Quigley HA. Long term results of glaucoma surgery among participants in an east African population survey. Br J Ophthalmol. 2000;84(8):860–864. doi:10.1136/bjo.84.8.860.
  • Bowman RJC, Hay A, Wood ML, Murdoch IE. Combined cataract and trabeculectomy surgery for advanced glaucoma in East Africa; visual and intra-ocular pressure outcomes. Eye (Lond). 2010;24(4):573–577.
  • Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Canaloplasty for primary open-angle glaucoma: long-term outcome. Br J Ophthalmol. 2010;94(11):1478–1482. doi:10.1136/bjo.2009.163170.
  • Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. 1999;25(3):316–322. doi:10.1016/s0886-3350(99)80078-9.
  • Kyari F, Nolan W, Gilbert C. Ophthalmologists‘ practice patterns and challenges in achieving optimal management for glaucoma in Nigeria: results from a nationwide survey. BMJ Open. 2016;6(10):e012230. doi:10.1136/bmjopen-2016-012230.
  • Yoshikawa K, Santo K, Hizaki H, Hashimoto M. Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model. Clin Ophthalmol. 2018;12:1617–1624. doi:10.2147/OPTH.S172273.
  • Leske MC, Connell AM, Wu SY, Nemesure B, Li X, Schachat AHA. Incidence of open-angle glaucoma. Arch Ophthalmol. 2001;119:89–95.
  • Hennis A, Wu S-Y, Nemesure B, Honkanen R, Leske MC. Awareness of incident open-angle glaucoma in a population study. the Barbados eye studies. Ophthalmology. 2007;114(10):1816–1821. doi:10.1016/j.ophtha.2007.06.013.
  • Adedayo Omobolanle AO, Onua O. Economic burden of glaucoma in Rivers State, Nigeria. Clin Ophthalmol. 2012;6:2023–2031. doi:10.2147/OPTH.S37145.
  • Ocansey S, Kyei S, Diafo A, Darfor KN, Boadi-Kusi SB, Aglobitse PB. Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities. BMC Health Serv Res. 2016;16(1):282. doi:10.1186/s12913-016-1528-x.
  • Omoti AE, Edema OT, Akpe BA, Musa P. Cost analysis of medical versus surgical management of glaucoma in Nigeria. J Ophthalmic Vis Res. 2010;5:232–239.
  • Mehari T, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral. BMC Ophthalmol. 2016;16:1–8. doi:10.1186/s12886-016-0316-z.
  • Tamrat L, Gessesse GW, Gelaw Y. Adherence to topical glaucoma medications in Ethiopian patients. Middle East Afr J Ophthalmol. 2015;22(1):59–63. doi:10.4103/0974-9233.148350.
  • Santos MAK, Ayena DK, Kuaovi KR, Vonor K, Djagnikpo A, Balo KP. [Compliance with medical treatment in primary open-angle glaucoma in Lome]. J Fr Ophtalmol. 2016;39(5):459–466. doi:10.1016/j.jfo.2015.10.013.
  • Gessesse G, Gelaw Y, Tamrat L. Adherence to topical glaucoma medications in Ethiopian patients. Middle East Afr J Ophthalmol. 2015;22(1):59. doi:10.4103/0974-9233.148350.
  • Anbesse DH, Yibekal BT, Assefa NL. Adherence to topical glaucoma medications and associated factors in Gondar university hospital tertiary eye care center, northwest Ethiopia. Eur J Ophthalmol. 2019;29(2):189–195. doi:10.1177/1120672118772517.